Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Skibsted Russell
Relationship:   Chief Financial Office...
City:   South San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   116,605    

Indirect Shares

  10,000      
Direct Value   $45,177    

Indirect Value

  $0      
Total Shares   126,605      
Total Value   $45,177      


Aeolus Pharmaceuticals Inc
 $0 Lineage Cell Therapeutics Ord Shs
 $22,149 Alimera Sciences Inc
 $23,028 Aeolus Pharmaceuticals Inc
 $0 Lineage Cell Therapeutics Ord Shs
 $22,149 Alimera Sciences Inc
 $23,028
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Aeolus Pharmaceuticals Inc AOLS Chief Financial Officer 2012-05-23 17,027 2011-05-18 10,000    Premium*  
            Lineage Cell Therapeutics Ord Shs LCTX Chief Financial Officer 2018-12-18 24,078 2017-08-23 0    Premium*  
            Alimera Sciences Inc ALIM Chief Financial Office... 2023-03-26 75,500 2023-01-09 0    Premium*  
* Premium Members only  

Records found :    10         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
ALIM Alimera Sciences Inc Chief Financial Officer & SVP   •       –      –    2023-01-09 4 A $0.00 $0 D/D 17,500 17,500 0 -
ALIM Alimera Sciences Inc Chief Financial Officer & SVP   •       –      –    2023-03-26 4 A $0.00 $0 D/D 58,000 75,500 0 -
AOLS Aeolus Pharmaceuticals In... Chief Financial Officer   •       –      –    2011-05-18 4 B $0.41 $4,150 D/D 10,000 10,000 2.66 -
AOLS Aeolus Pharmaceuticals In... Chief Financial Officer   •       –      –    2011-05-18 4 B $0.43 $4,300 I/I 10,000 10,000 1.91 -
AOLS Aeolus Pharmaceuticals In... Chief Financial Officer   •       –      –    2012-05-23 4 B $0.24 $1,678 D/D 7,027 17,027 2.66 -
LCTX Lineage Cell Therapeutics... Chief Financial Officer   •       –      –    2017-08-23 4 B $2.64 $5,285 D/D 2,000 2,000 2.74 -
LCTX Lineage Cell Therapeutics... Chief Financial Officer   •       –      –    2018-10-04 4 OE $0.00 $0 D/D 11,250 13,250 0 -
LCTX Lineage Cell Therapeutics... Chief Financial Officer   •       –      –    2018-10-04 4 D $2.22 $8,638 D/D (3,891) 9,359 0 -
LCTX Lineage Cell Therapeutics... Chief Financial Officer   •       –      –    2018-12-18 4 OE $0.00 $0 D/D 22,500 31,859 0 -
LCTX Lineage Cell Therapeutics... Chief Financial Officer   •       –      –    2018-12-18 4 D $1.03 $8,014 D/D (7,781) 24,078 0 -

  10  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed